IMMUNOGENICITY
Clinical trials for IMMUNOGENICITY explained in plain language.
Never miss a new study
Get alerted when new IMMUNOGENICITY trials appear
Sign up with your email to follow new studies for IMMUNOGENICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Mpox vaccine trial for infants: could a Half-Dose protect just as well?
⭐️ VACCINE ⭐️ OngoingThis Phase 3 study is testing the MVA-BN mpox vaccine in 344 infants and children aged 4 to 24 months in the Democratic Republic of the Congo, a region heavily affected by mpox. Researchers are comparing a standard dose to a half-dose to see if the lower dose is still effective a…
Matched conditions: IMMUNOGENICITY
Phase: PHASE3 • Sponsor: Jean-Pierre Van geertruyden • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:25 UTC
-
Mpox vaccine trial for pregnant women launches in congo
⭐️ VACCINE ⭐️ OngoingThis Phase 3 trial is testing the safety and immune response of the MVA-BN mpox vaccine in 359 pregnant and postpartum women in the Democratic Republic of the Congo. Some women receive the vaccine during pregnancy, others right after giving birth, and a small group gets it as an …
Matched conditions: IMMUNOGENICITY
Phase: PHASE3 • Sponsor: Jean-Pierre Van geertruyden • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:00 UTC
-
BREATH study: tracking biologic drug effects in severe asthma
Knowledge-focused OngoingThis study watches 100 people with severe asthma who are taking biologic drugs. Researchers measure how the body reacts to the drug and whether it affects asthma attacks. The goal is to learn more about drug effectiveness and safety.
Matched conditions: IMMUNOGENICITY
Sponsor: Samsung Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC